Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ravi P. Nargund is active.

Publication


Featured researches published by Ravi P. Nargund.


Archive | 2004

Melanocortin receptor agonists

Raman K. Bakshi; Ravi P. Nargund; Zhixiong Ye


Archive | 2001

Substituted piperidines as melanocortin-4 receptor agonists

Brenda L. Palucki; Khaled J. Barakat; Liangqin Guo; Yingjie Lai; Ravi P. Nargund; Min K. Park; Patrick G. Pollard; Iyassu K. Sebhat; Zhixiong Ye


Archive | 2002

Bridged piperidine derivatives as melanocortin receptor agonists

Zhixiong Ye; Khaled J. Barakat; Liangqin Guo; Ravi P. Nargund; Iyassu K. Sebhat


Archive | 2008

Beta carboline derivatives as antidiabetic compounds

Peter H. Dobbelaar; Wu Du; Liangqin Guo; William K. Hagmann; Shuwen He; Tianying Jian; Jian Liu; Ravi P. Nargund; Alexander Pasternak; Shrenik K. Shah; Quang T. Truong; Zhixiong Ye; James Dellureficio; Raman K. Bakshi


Archive | 2011

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN AND OTHER INDICATIONS

Harry R. Chobanian; Linus S. Lin; Ping Liu; Marc D. Chioda; Robert J. DeVita; Ravi P. Nargund; Yan Guo; Terence G. Hamill; Wenping Li; Darrell A. Henze


Archive | 2007

Substituted imidazoles as bombesin receptor subtype-3 modulators

David Chen; Christopher L. Franklin; Peter R. Guzzo; Linus S. Lin; Jian Liu; Michael M. C. Lo; Ravi P. Nargund; Iyassu K. Sebhat


Archive | 2012

Compounds as dgat-1 inhibitors

Robert J. DeVita; Shuwen He; Jian Liu; Timothy A. Cernak; Arto D. Krikorian; Ginger X. Yang; Zhicai Wu; Yang Yu; Dong-Ming Shen; Zhong Lai; Qingmei Hong; Ravi P. Nargund


Archive | 2012

Lactam derivatives as dgat-1 inhibitors

Thomas Graham; Dong-Ming Shen; Ravi P. Nargund; Robert J. DeVita; Yang Yu; Wensheng Liu


Archive | 2017

composição farmacêutica, e, uso da composição

Darrell A. Henze; Harry R. Chobanian; Linus S. Lin; Marc D. Chioda; Ping Liu; Ravi P. Nargund; Robert J. DeVita; Terence G. Hamill; Wenping Li; Yan Guo


Archive | 2017

composto, composição farmacêutica, uso de um composto, e, método de tratamento ou de prevenção de um transtorno, de uma condição ou de uma doença

Bin Hu; Bing Li; Christopher W. Plummer; Derun Li; Hubert Josien; Jinglai Hao; Linus S. Lin; Mingxiang Cui; Purakkattle J. Biju; Qun Dang; Ravi P. Nargund; Timothy A. Blizzard; William K. Hagmann; Zhengxia Chen

Collaboration


Dive into the Ravi P. Nargund's collaboration.

Researchain Logo
Decentralizing Knowledge